Molecular Diagnostics

New Partnership Aims to Expand Access to AI-Driven Cancer Genomic Testing

The collaboration combines AI-based analysis tools with a next-generation sequencing system to support labs performing tumor and liquid biopsy testing.

Molecular Diagnostics

EazeBio Partners with UC Santa Cruz to Develop Instrument-Free Diagnostics

The collaboration will focus on creating a cortisol biosensor for stress and metabolic health testing using luminescent biosensors and AI-guided interpretation.

Molecular Diagnostics

Thermo Fisher Launches Molecular Diagnostic System for Lung Transplant Rejection Assessment

The machine learning-powered platform analyzes gene expression data from biopsies to provide molecular scores for rejection probability and tissue injury.

Hitachi High-Tech, ELITech Partner on Automated PCR Testing Platform

Sep 26, 2025 | Molecular Diagnostic Analyzers

The companies plan to create a fully automated PCR testing system for infectious disease diagnosis and treatment monitoring.

Ultima Genomics’ ppmSeq Technology Shows Ultra-Low Error Rates for MRD Detection

Sep 26, 2025 | Sequencing Systems

New research demonstrates the ultra-sensitive SNV detection capabilities of ppmSeq technology, with error rates reaching as low as 8 x 10-8 for minimal residual disease applications.

bioMérieux Receives FDA Clearance for Anterior Nasal Swab Testing on Spotfire Platform

Sep 25, 2025 | Amplification Technologies

The French diagnostics company announced the clearance allows healthcare professionals to collect specimens by swabbing only the anterior part of the nasal cavity.

Lunit and Agilent Partner to Develop AI-Powered Companion Diagnostics

Sep 24, 2025 | Molecular Diagnostic Analyzers

The collaboration combines Lunit’s AI expertise with Agilent’s diagnostic leadership to improve biomarker testing and enhance precision medicine capabilities.

Myriad Genetics, SOPHiA GENETICS Partner on Global Liquid Biopsy Companion Diagnostic

Sep 24, 2025 | Molecular Diagnostic Analyzers

The collaboration combines Myriad’s US laboratory capabilities with SOPHiA’s decentralized network of more than 800 institutions across 70-plus countries.

Seegene, Springer Nature Launch $600K Grant Program for UTI Antibiotic Resistance Research

Sep 23, 2025 | Amplification Technologies

The program focuses on antibiotic resistance in urinary tract infections, with applications open until Nov 20.

PacBio Launches HiFi Sequencing Platform for Carrier Screening Market

Sep 22, 2025 | Sequencing Systems

The updated solutions leverage PacBio’s HiFi sequencing technology to allow clinical laboratories to consolidate multiple specialized assays into a single, scalable test.

Enhanced PCR Reporting Service Applies CLSI Guidelines to UTI Results

Sep 18, 2025 | Molecular Diagnostic Analyzers

The service applies CLSI M100 guidelines to PCR reports, delivering insights on pathogens and resistance markers to support labs and physicians.

Rare Disease Test Expanded to Include Tandem Repeat and Mitochondrial Analysis

Sep 18, 2025 | Sequencing Systems

The expanded testing capabilities leverage long-read sequencing technology to detect disorders such as Fragile X syndrome, adult neurological conditions, certain ataxias, and more.

CLIA Accreditation Clears Path for CNSide Diagnostics’ CSF Assay Platform

Sep 18, 2025 | Molecular Diagnostic Analyzers

Houston-based facility meets federal regulatory requirements for cerebrospinal fluid testing to detect central nervous system metastases.

CMS Sets Preliminary Payment Rate for Optical Genome Mapping CPT Code

Sep 16, 2025 | Molecular Diagnostics

The new Category I code for constitutional genetic disorders receives crosswalk pricing of $1,263.53, higher than comparable microarray codes.

New qPCR Multiplexing Probes Aim to Reduce Turnaround Times and Streamline Ordering

Sep 11, 2025 | Molecular Diagnostics

The probes allow up to 5-plex multiplexing and are paired with a modernized online tool for ordering qPCR components.

AI Companion Tool Identifies Food Triggers Based on IBS Sensitivity Testing

Sep 11, 2025 | Molecular Diagnostics

A new AI-powered platform provides meal suggestions, ingredient substitutions, and meal planning guidance to help patients avoid their identified trigger foods.